Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivotal multicenter non-comparative trial of LF111 oral contraceptive (drospirenone)
2010-021787-15Phase 3Completed
- Sponsor
- Laboratorios Leon Farma
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of drospirenone, sponsored by Laboratorios Leon Farma. Primary endpoint: Contraceptive efficacy of LF111. Started Nov 2010; status: completed.
02
Drugs
drospirenone
Beyond the preview
Go deeper on 2010-021787-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021787-15.